LIIKANEN SPEECH
October 1st, 2002
BY KEITH NUTHALLEU enterprise Commissioner Erkki Liikanen has called on European governments and public institutions to examine further ways of encouraging the pharmaceutical industry to spend more on research and development into medicines for rare diseases. Highlighting the special marketing rights granted in the EU to orphan drugs, the Commissioner told a Brussels roundtable on the subject: "We should more and more find means to get the pharmaceutical industry involved in clear and targeted projects." Signalling that such a policy would entail public help for ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.